Evidence map›Paper›PMID 36661723›Full record

ReviewCurrent oncology (Toronto, Ont.)2023

Interventions for the Prevention of Oral Mucositis in Patients Receiving Cancer Treatment: Evidence from Randomised Controlled Trials.

Giuseppe Colella, Ciro Emiliano Boschetti, Rita Vitagliano, Chiara Colella, Lebei Jiao, Natalie King-Smith, Chong Li, Yii Nuoh Lau, Zacchaeus Lai, Ali Ibrahim Mohammed and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 7 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 7 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Photobiomodulation for oral mucositis in cancer care: prevention, clinical management, and evidence from randomized controlled trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. N-acetylcysteine mouthwash for prevention of oral mucositis in hematopoietic cell transplant recipients: a double-blind randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  9. ONCOllab for Transmission of Knowledge Related to Oral Complications of Cancer Therapy Among Dental Students.European journal of dental education : official journal of the Association for Dental Education in Europe · 2026
    Trial
  10. Trial
  11. Trial
  12. Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Healing Oral Mucositis WithBioMed research international · 2025
    Trial
  19. Trial
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Giuseppe ColellaMultidisciplinary Department of Medical-Surgical and Dental Specialties, Oral and Maxillofacial Surgery Unit, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.ORCID 0000-0003-4197-9617
Ciro Emiliano BoschettiMultidisciplinary Department of Medical-Surgical and Dental Specialties, Oral and Maxillofacial Surgery Unit, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Rita VitaglianoMultidisciplinary Department of Medical-Surgical and Dental Specialties, Oral and Maxillofacial Surgery Unit, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.ORCID 0000-0002-1920-2679
Chiara ColellaMultidisciplinary Department of Medical-Surgical and Dental Specialties, Oral and Maxillofacial Surgery Unit, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Lebei JiaoMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.
Natalie King-SmithMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.
Chong LiMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.
Yii Nuoh LauMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.
Zacchaeus LaiMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.
Ali Ibrahim MohammedMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.ORCID 0000-0003-0017-5233
Nicola CirilloMelbourne Dental School, The University of Melbourne, Carlton, Melbourne, VIC 3053, Australia.ORCID 0000-0003-1429-1323
The University of Melbourne · AUUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral mucositis is a common and most debilitating complication associated with cancer therapy. Despite the significant clinical and economic impact of this condition, there is little to offer to patients with oral mucositis, and the medications used in its management are generally only palliative. Given that mucositis is ultimately a predictable and, therefore, potentially preventable condition, in this study we appraised the scientific literature to evaluate effective methods of prevention that have been tested in randomised controlled trials (RCTs). Published high-level evidence shows that multiple preventative methods are potentially effective in the prevention of oral mucositis induced by radiotherapy, chemotherapy, or both. Anti-inflammatory medications (including benzydamine), growth factors and cytokines (including palifermin), cryotherapy, laser-and-light therapy, herbal medicines and supplements, and mucoprotective agents (including oral pilocarpine) showed some degree of efficacy in preventing/reducing the severity of mucositis with most anticancer treatments. Allopurinol was potentially effective in the prevention of radiotherapy-induced oral mucositis; antimicrobial mouthwash and erythropoietin mouthwash were associated with a lower risk of development of severe oral mucositis induced by chemotherapy. The results of our review may assist in highlighting the efficacy and testing the effectiveness of low-cost, safe preventative measures for oral mucositis in cancer patients.

Indexed as

MucositisNeoplasmsStomatitisAnti-Inflammatory AgentsHumansMouthwashesRandomized Controlled Trials as TopicAnti-Inflammatory AgentsMouthwasheschemotherapyoral mucositispreventative agentsradiotherapy

Identifiers

PMID36661723
PMCPMC9858113
OpenAlexW4315646642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.